Skip to main content
. 2018 Aug 19;7(9):4485–4495. doi: 10.1002/cam4.1742

Table 1.

Characteristics of women diagnosed with high‐grade endometrial cancer, CCR 1998‐2009 by race/ethnicity

NH White NH Black Hispanic Asian/PI Chi‐square P value
N % N % N % N %
Age
<50 431 6.3 56 5.4 261 15.6 150 13.5 <0.0001
50‐59 1355 19.9 196 18.8 417 24.9 343 30.9
60‐69 1850 27.1 412 39.5 517 30.9 314 28.3
70‐79 1836 26.9 268 25.7 331 19.8 206 18.5
80+ 1348 19.8 111 10.6 147 8.8 98 8.8
Histologic subtype
Serous 1113 16.3 254 24.4 316 18.9 188 16.9 <0.0001
High‐grade endometrioid 3141 46.1 331 31.7 699 41.8 508 45.7
Clear cell 344 5.0 61 5.8 90 5.4 63 5.7
Carcinosarcoma/Mullerian mixed 1094 16.0 260 24.9 304 18.2 173 15.6
Mixed 1128 16.5 137 13.1 264 15.8 179 16.1
FIGO stage equivalent
I 3126 45.8 411 39.4 705 42.1 484 43.6 <0.0001
II 614 9.0 111 10.6 162 9.7 99 8.9
III 1574 23.1 244 23.4 394 23.6 290 26.1
IV 1241 18.2 217 20.8 347 20.7 215 19.4
Unknown 265 3.9 60 5.8 65 3.9 23 2.1
Number LN examined
None 2061 30.2 423 40.6 585 35.0 282 25.4 <0.0001
1‐9 1432 21.0 223 21.4 314 18.8 244 22.0
10 or more 3059 44.9 368 35.3 731 43.7 555 50.0
Unknown 268 3.9 29 2.8 43 2.6 30 2.7
Number LN positivea
None 3528 74.1 424 68.4 785 72.2 592 71.4 0.0820
1 379 8.0 62 10.0 105 9.7 85 10.3
2‐5 528 11.1 77 12.4 122 11.2 90 10.9
>5 255 5.4 49 7.9 64 5.9 52 6.3
Unknown 69 1.4 8 1.3 12 1.1 10 1.2
Radiation
None 4379 64.2 711 68.2 1037 62.0 679 61.1 0.0241
External Beam 1509 22.1 206 19.8 406 24.3 295 26.6
Brachytherapy 330 4.8 44 4.2 77 4.6 39 3.5
Beam + Brachytherapy 542 7.9 72 6.9 142 8.5 91 8.2
Radiation, NOS 59 0.9 10 1.0 11 0.7 7 0.6
Unknown <5 0.0 0 0 0 0 0 0
Chemotherapy
No 5041 73.9 759 72.8 1128 67.4 756 68.0 <0.0001
Yes 1779 26.1 284 27.2 545 32.6 355 32.0
Charlson Comorbidity Index
Unknown 318 4.7 64 6.1 172 10.3 87 7.8 <0.0001
0 4500 66.0 535 51.3 936 55.9 697 62.7
1 1379 20.2 255 24.4 388 23.2 250 22.5
2+ 623 9.1 189 18.1 177 10.6 77 6.9
Neighborhood SES quintile
1‐ Lowest SES 573 8.4 315 30.2 515 30.8 108 9.7 <0.0001
2 1104 16.2 279 26.7 438 26.2 192 17.3
3 ‐ Middle SES 1521 22.3 212 20.3 326 19.5 232 20.9
4 1660 24.3 148 14.2 240 14.3 284 25.6
5 ‐ Highest SES 1962 28.8 89 8.5 154 9.2 295 26.6
Primary payer
None 87 1.3 25 2.4 97 5.8 36 3.2 <0.0001
Private 3548 52.0 520 49.9 778 46.5 605 54.5
Public/Medicaid, VA 489 7.2 178 17.1 396 23.7 221 19.9
Medicare 2469 36.2 302 29.0 333 19.9 205 18.5
Unknown 227 3.3 18 1.7 69 4.1 44 4.0
Seen at NCI‐designated cancer center
No 6069 89.0 913 87.5 1367 81.7 913 82.2 <0.0001
Yes 751 11.0 130 12.5 306 18.3 198 17.8
Total 6820 100.0 1043 100.0 1673 100.0 1111 100.0
a

Among women with lymph nodes removed.